Skip to content

Effectiveness of dayclinic treatment for adolescents with personality developmental disorders with techniques of the transference focused psychotherapy for adolescents (TFP-A)

Effectiveness of dayclinic treatment for adolescents with personality developmental disorders with techniques of the transference focused psychotherapy for adolescents (TFP-A)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00010557
Enrollment
160
Registered
2020-08-27
Start date
2016-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F60-F69

Interventions

Group 1: The sample will consist of 80 adolescent out-patients from 13- 17 years of age who seek treatment for a personality developmental disorder in our day clinic program at the Department for Chil

Sponsors

Uniklinik KölnKlinik für Kinder- und Jugendpsychiatrie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 17 Years

Inclusion criteria

Inclusion criteria: For inclusion into the study a written consent form for the study is necessary signed after informed consent (about the procedure of the study as well as their voluntary involvement and the freedom to terminate the participation at any time) by the adolescent who is above 14 years of age or by the parents for patients who are 13 years of age. All patients need to be between 13 to 17 years of age, they have to fulfill at least probable criteria for a personality disorder based on the International Personality Disorder Examination, conducted by a reliable interviewer. Inclusion criteria for target sample and control sample: Existance of a personality disorder on the Basis of DSM-IV (IPD) Inclusion criteria for target sample: Treatment in dayclinic. Inclusion criteria for Waitinggroup: Existence of a personality disorder and written consent to participate.

Exclusion criteria

Exclusion criteria: Exclusion criteria are missing reading knowledge of the German language; an IQ below 70, a disorder from the schizophrenic spectrum; any other disorders of perception, cognition and affectivity which influence neuropsychological testing; a change of medication which influences the CNS during the dayclinic treatment program. Medication which has already been given before inclusion into the program does not fulfill an exclusion criterion.

Design outcomes

Primary

MeasureTime frame
Primary Endpoint after 12 weeks of Treatment in the dayclinic. Outcome Parameter: Borderline Symptoms (DAPP; IPO), Aggression and autoaggression (MOAS, FSSV), capability of relationship (IIP). Katamnese after another 3 months

Secondary

MeasureTime frame
Secondary Endpouint after another 3 months. Secondary Outcome Parameter: Borderline Symptoms (DAPP; IPO), Aggression and autoaggression (MOAS, FSSV), capability of relationship (IIP).

Countries

Germany

Contacts

Public ContactSabine Prill

Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters am Klinikum der Universität zu Köln

sabine.prill@uk-koeln.de0221/478-98272

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026